Enalapril
0,01 g № 50
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Tablets
ATC code
C09AA02
RX/OTC
RX
Registration certificate
UA/2818/01/01
General properties
Pharmacotherapeutic group
ACE inhibitors. Enalapril.
Therapeutic indications
- Treatment of arterial hypertension.
- Treatment of symptomatic heart failure.
- Prevention of symptomatic heart failure in patients with asymptomatic left ventricular dysfunction (ejection fraction £ 35%).
Contraindications
Hypersensitivity to enalapril, to any excipients and to any other ACE inhibitor. Presence in anamnesis of of angioedema associated with the use of ACE inhibitors. Hereditary or idiopathic angioedema. Enalapril should not be used with medications containing aliskiren, by patients with diabetes or impaired kidney function (GFR <60 mL / min / 1.73 m2). Pregnant women or women who plan to become pregnant (see."Pregnancy and breast-feeding" section).
Pharmaceutical characteristics
Main physicochemical properties
Tablets of wite or almost white color with separative mark.
Shelf life
3 years.
Storage
Keep out of reach of children in the original packaging at a temperature not exceeding 25 °C.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
